MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611087757 A) filed by Diksha; Dr. Prevesh Kumar; Dr. Neelkant Prasad; and Dr. Navneet Verma on July 17, 2026, for Inhalable Dry Powder Formulation Of Exosome-Encapsulated Antisense Oligonucleotides For Pulmonary Fibrosis Treatment.
Inventors include Diksha; Dr. Prevesh Kumar; Dr. Neelkant Prasad; and Dr. Navneet Verma.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present disclosure relates to an inhalable dry powder pharmaceutical composition comprising exosome-encapsulated antisense oligonucleotides (ASOs) for the treatment and/or prevention of pulmonary fibrosis. The composition com...